Non-Therapeutic Biomolecules Market Report 2026

Non-Therapeutic Biomolecules Market Overview

• Non-Therapeutic Biomolecules market size has reached to $33.92 billion in 2025 • Expected to grow to $56.43 billion in 2030 at a compound annual growth rate (CAGR) of 10.7% • Growth Driver: The Surging Demand For Non-Therapeutic Biomolecules In Research And Laboratory Testing • Market Trend: Advancements in Cell Separation Technologies Enhancing Efficiency • Asia-Pacific was the largest region in 2025.

What Is Covered Under Non-Therapeutic Biomolecules Market?

Non-therapeutic biomolecule refers to the organic compounds created by cells and living things. These compounds come in a wide range of shapes and sizes and carry out a wide variety of tasks in body functioning. The main types of trad pharma of non-therapeutic biomolecules are enzymes, recombinant proteins, plasmids, peptides, oligonucleotides, and monoclonal antibodies. Enzymes are globular conjugated proteins that catalyze biological reactions by reducing the activation energy that increases the rate of the reaction. These are used by various end users such as research, pharma and In vitro diagnostics(IVD).

What Is The Non-Therapeutic Biomolecules Market Growth Forecast?

The non-therapeutic biomolecules market size is expected to see rapid growth in the next few years. It will grow to $56.43 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to expansion in synthetic biomolecule applications, growing investment in precision medicine, increasing use in agricultural biotechnology, rising focus on sustainable and scalable biomolecule production, innovations in automated biomolecule synthesis platforms. Major trends in the forecast period include advanced protein engineering, high-throughput screening technologies, sustainable biomolecule production, cell-free biomolecule synthesis, customizable biomolecule platforms.

What Is The Driver Of The Non-Therapeutic Biomolecules Market?

The rapidly increasing number of research and laboratory testing is expected to propel the growth of the non-therapeutic biomolecules market going forward. Laboratory testing refers to the medical procedure that involves testing a sample of blood, urine, or other substance from the body to determine and monitoring of disease and draft a treatment plan, whereas research refers to the new knowledge is created, or current knowledge is creatively applied to produce new concepts, theories, and understandings. Non-therapeutic biomolecules in laboratory testing are used to measure the presence or concentration of a biomarker molecule that indicates disease, to enhance the sensitivity and specificity of the test. For instance, in July 2024, according to the National Health Service (NHS), a UK-based hospital and health care provider, diagnostic activity exceeded pre-pandemic levels in 2023, with a 21% increase in tests performed in May 2024 compared to 2023. Therefore, the rapidly increasing number of research and laboratory testing is driving the growth of the non-therapeutic biomolecules industry.

Key Players In The Global Non-Therapeutic Biomolecules Market

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Eppendorf AG, Bio-Techne Corporation, Vectalys, Avid Bioservices Inc.

Global Non-Therapeutic Biomolecules Market Trends and Insights

Major companies in the non-therapeutic biomolecules market are focusing on developing new cell separation technology to increase throughput and optimize processes, thus gaining a competitive advantage in the market. This innovative research-only kit is created to provide scientists with a crucial solution to biological and lab workflow difficulties. For instance, in May 2023, AcouSort AB, a Sweden-based biotechnology company, launched the AcouTrap 3 system. The system combines the unique features of acoustofluidics, integrating sound waves with microfluidics, to offer a streamlined solution for cell and extracellular vesicle isolation in a single workflow. The AcouTrap 3 system employs gentle acoustic trapping technology, allowing scientists to process more samples with higher cell viability and minimal loss compared to traditional column- or bead-based methods, thereby increasing productivity and optimizing laboratory operations.

What Are Latest Mergers And Acquisitions In The Non-Therapeutic Biomolecules Market?

In December 2023, Danaher Corporation, a US-based life sciences and diagnostics conglomerate providing laboratory instruments, reagents, and consumables, acquired Abcam plc for an undisclosed amount. With this acquisition, Danaher aims to broaden its non-therapeutic biomolecule portfolio and strengthen its research-reagent business by integrating Abcam’s antibodies, proteins, and immunoassay products into its global distribution and solutions platform. Abcam plc is a UK-based provider of research-use antibodies, proteins, immunoassays, and other reagent tools used in drug discovery, diagnostics, and academic research.

What Defines the Non-Therapeutic Biomolecules Market?

The non-therapeutic biomolecule market consists of sales of monosaccharides, disaccharides, polysaccharides, heteropolysaccharides, structural proteins, hormones, respiratory pigments, storage proteins, toxins, deoxyribonucleic acids (DNA), ribonucleic acids (RNA), fatty acids, phospholipids, steroids, eicosanoids, and glycolipids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Non-Therapeutic Biomolecules Market Report 2026?

The non-therapeutic biomolecules market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the non-therapeutic biomolecules industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.